Continuing declines in COVID-19 test revenues was a common theme during the first quarter 2023 earning reports released by the nation’s largest in vitro diagnostics (IVD) manufacturers. At the same time, there was optimism as different IVD firms highlighted advancement and business opportunities in the following areas: • Digital pathology. • Companion diagnostics. • New …
Despite COVID-19 Losses, IVD Executives Remain Upbeat Read More »
